Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

NCT00268463 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

22

Enrollment

NETWORK

Sponsor class

Stopped The study was terminated due to low accrual.

Conditions

Colorectal Cancer
Metastatic Cancer

Interventions

DRUG: capecitabine
DRUG: floxuridine
DRUG: oxaliplatin

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]